Omicron grows 70 times faster than Delta in bronchial tissue
December 16, 2021Business Services
The COVID-19 variant, Omicron, has been found to replicate around 70 times faster than the original and Delta variants of …
Potential drugs for AMD treatment identified using stem-cell based research
December 16, 2021Business Services
Researchers at the National Institutes of Health (NIH) have identified two drug candidates to slow dry age-related macular degeneration (AMD), …
FDA pauses several trials of Merck’s investigational HIV drug
December 16, 2021Business Services
The FDA has placed holds on several clinical trials for the oral and implant formulations of investigation drug islatravir (MK-8591), …
European Commission backs Johnson & Johnson COVID-19 booster for adults
December 16, 2021Business Services
The EC has recommended a booster dose of Johnson & Johnson’s COVID-19 vaccine at least two months after a first …
Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation
December 15, 2021Research and Development
Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …
Bionaut Labs and Candel Therapeutics collaborate to deliver immunotherapies
December 15, 2021Research and Development
Bionaut Labs, and Candel Therapeutics, have announced a strategic collaboration to investigate the use of Bionaut’s remote-controlled microscale robots for …
Positive results in Phase III trial of candidemia and invasive candidiasis
December 15, 2021Research and Development
Cidara Therapeutics and Mundipharma have announced positive topline data from the ReSTORE Phase III clinical trial, evaluating the efficacy and …
Sanofi and GSK announce positive booster data for COVID-19 vaccine candidate
December 15, 2021Research and Development
Sanofi and GSK have announced positive preliminary booster data for their COVID-19 vaccine candidate, and continuation of their Phase III …
European Commission approves Pfizer drug for adults with moderate-to-severe atopic dermatitis
December 14, 2021Manufacturing and Production
The EC has approved the investigational once-daily Janus kinase 1 (JAK1) inhibitor, abrocitinib, for the treatment of moderate-to-severe atopic dermatitis …
India’s Serum Novavax jab to be launched for children in six months
December 14, 2021Medical Communications
The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six …
Phase III trial results gives hope to B-Cell lymphoma patients
December 14, 2021Manufacturing and Production
Bristol Myers Squibb (BMS) reported that interim assessment data from the Phase III TRANSFORM clinical trial of Breyanzi (lisocabtagene maraleucel; …
Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy
December 14, 2021Medical Communications
Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …
Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director
December 13, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
CAR-T therapy trials show promise for earlier use in lymphoma
December 13, 2021Sales and Marketing
Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …
New clinical trial testing diabetes drug for reducing risk of Alzheimer’s
December 13, 2021Sales and Marketing
A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …
UK government sets new booster target
December 13, 2021Sales and Marketing
The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …
Feedback receives funding for cloud-based tuberculosis programme
December 13, 2021Sales and Marketing
Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …
CDC authorise Pfizer boosters for 16- and 17-year-olds
December 10, 2021Medical Communications
The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …
FDA approves expansion for ZYNRELEF
December 10, 2021Medical Communications
The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …
Novartis announces positive results from Phase III trial of Beovu
December 9, 2021Business Services
Novartis have announced the first interpretable results from year two (week 100) of the Phase III KESTREL study. KESTREL assessed …
Latest content
